20
Participants
Start Date
February 28, 2007
Primary Completion Date
February 28, 2007
Study Completion Date
February 28, 2010
MPHOSPH1 and DEPDC1
DEPDC1-9-294, and/or MPHOSPH1-9-278 will be administered by subcutaneously injection once every week for 3 months thereafter once two weeks. These peptides are determined to administer in accordance with the protein expression using immunohistochemical staining. These peptides are conjugated with Montanide ISA 51 as an adjuvant.
Iwate Medical University School of Medicine, Morioka
Human Genome Center, Institute of Medical Science, University of Tokyo
OTHER
Iwate Medical University
OTHER